The United States has doubled its investment to nearly $1 billion to expedite development of a potential COVID-19 vaccine by...
Read more
Heron Therapeutics, a commercial-stage biotechnology company, announced the initiation of the GUARDS-1 Study, a phase 2 clinical study evaluating Cinvanti...
Read more
Eli Lilly and Company announced that mirikizumab, an investigational monoclonal antibody that binds to the p19-subunit of IL23, met the...
Read more
Gilead Sciences, Inc. announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia. This...
Read more
Takeda Pharmaceutical Company Limited announced it will orally present the results of two studies at the 25th Congress of the...
Read moreThe drug development firm has introduced COVID-19 Clinical Trial Connect, a site designed to help potential patients match with research...
Read more
Johnson & Johnson announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2a...
Read more
Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a...
Read moreSun Pharmaceutical Industries Ltd. announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug...
Read moreFSD Pharma Inc. received approval from the U.S. FDA to submit an Investigational New Drug Application (IND) for the use...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
